Royal Bank of Canada
GLSI icon

Royal Bank of Canada’s Greenwich LifeSciences GLSI Stock Holding History

Royal Bank of Canada’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
6
-992
-99% -$25.9K ﹤0.01% 7336
2025
Q4 		$20K Sell
998
-233
-19% -$2.45K ﹤0.01% 6042
2025
Q3 		$12K Buy
1,231
+584
+90% +$6.59K ﹤0.01% 6413
2025
Q2 		$6K Sell
647
-1,087
-63% -$10.3K ﹤0.01% 6598
2025
Q1 		$16K Buy
1,734
+1,108
+177% +$13.4K ﹤0.01% 5995
2024
Q4 		$7K Sell
626
-444
-41% -$5.94K ﹤0.01% 6447
2024
Q3 		$16K Buy
1,070
+509
+91% +$7.54K ﹤0.01% 6170
2024
Q2 		$10K Buy
561
+547
+3,907% +$7.99K ﹤0.01% 6333
2024
Q1 		$0 Sell
14
-10
-42% -$123 ﹤0.01% 7221
2023
Q4 		$0 Buy
24
+15
+167% +$150 ﹤0.01% 7292
2023
Q3 		$0 Sell
9
-97
-92% -$911 ﹤0.01% 7262
2023
Q2 		$1K Sell
106
-3
-3% -$34 ﹤0.01% 7002
2023
Q1 		$2K Sell
109
-591
-84% -$9.38K ﹤0.01% 6769
2022
Q4 		$11K Sell
700
-1
-0.1% -$11 ﹤0.01% 6504
2022
Q3 		$6K Sell
701
-699
-50% -$6.47K ﹤0.01% 6659
2022
Q2 		$12K Sell
1,400
-252
-15% -$2.89K ﹤0.01% 6303
2022
Q1 		$32K Sell
1,652
-564
-25% -$11.4K ﹤0.01% 6345
2021
Q4 		$54K Sell
2,216
-1,555
-41% -$52K ﹤0.01% 6334
2021
Q3 		$147K Buy
3,771
+695
+23% +$29K ﹤0.01% 5427
2021
Q2 		$138K Buy
3,076
+276
+10% +$10.4K ﹤0.01% 5377
2021
Q1 		$95K Buy
+2,800
New +$95.3K ﹤0.01% 5504

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Royal Bank of Canada's GLSI Position: Q1 2026 in Review

Royal Bank of Canada reduced its Greenwich LifeSciences (GLSI) stake by 99% in Q1 2026, selling an estimated $25.9K and leaving 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7336.

Royal Bank of Canada first reported a position in GLSI in Q1 2021 and has held it in 21 quarters since. The position peaked at $147K in Q3 2021. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Royal Bank of Canada held 6 shares of Greenwich LifeSciences worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 992 Greenwich LifeSciences shares in Q1 2026, an estimated $25.9K.
  • Greenwich LifeSciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7336 holding.
  • Royal Bank of Canada first reported a position in Greenwich LifeSciences in Q1 2021 and has held it in 21 quarters since.
  • Royal Bank of Canada's Greenwich LifeSciences position peaked at $147K in Q3 2021.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.